SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001638599-20-000657
Filing Date
2020-07-02
Accepted
2020-07-02 18:10:32
Documents
1
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT doc4_6775.html 4  
1 PRIMARY DOCUMENT doc4_6775.xml 4 9230
  Complete submission text file 0001638599-20-000657.txt   10614
Mailing Address 295 MADISON AVENUE, SUITE 2400 NEW YORK NY 10017
Business Address 295 MADISON AVENUE, SUITE 2400 NEW YORK NY 10017 813-766-9539
EYENOVIA, INC. (Issuer) CIK: 0001682639 (see all company filings)

IRS No.: 471178401 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address C/O EYENOVIA, INC. 501 FIFTH AVENUE, SUITE 1404 NEW YORK NY 10017
Business Address
Rowe Michael M (Reporting) CIK: 0001744774 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38365 | Film No.: 201011297